NPI: 1215989611 · CLEVELAND, OH 44111 · General Acute Care Hospital · NPI assigned 05/16/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 05/16/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 124,435 | $4.82M |
| 2019 | 121,353 | $5.06M |
| 2020 | 87,561 | $5.07M |
| 2021 | 125,883 | $6.34M |
| 2022 | 133,873 | $5.82M |
| 2023 | 518,429 | $21.34M |
| 2024 | 375,249 | $13.95M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 71,128 | 62,449 | $8.97M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 64,882 | 61,472 | $7.26M |
| 96361 | Intravenous infusion, hydration; each additional hour | 25,073 | 17,831 | $6.90M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 60,599 | 49,731 | $4.99M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 39,573 | 36,309 | $4.62M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 22,954 | 20,553 | $3.06M |
| G0378 | Hospital observation service, per hour | 29,431 | 13,807 | $2.24M |
| J9271 | Injection, pembrolizumab, 1 mg | 263 | 133 | $2.10M |
| 70450 | Computed tomography, head or brain; without contrast material | 5,989 | 4,911 | $1.43M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10,113 | 9,609 | $1.08M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5,101 | 4,214 | $1.03M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7,493 | 6,561 | $993K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 5,166 | 2,497 | $907K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7,135 | 5,333 | $883K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,648 | 3,086 | $767K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3,412 | 2,836 | $657K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 5,074 | 4,027 | $618K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8,798 | 4,189 | $542K |
| 80053 | Comprehensive metabolic panel | 86,178 | 68,195 | $537K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5,729 | 4,857 | $527K |
| 59025 | Fetal non-stress test | 3,440 | 2,393 | $509K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5,905 | 4,869 | $505K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,652 | 2,174 | $457K |
| J2350 | Injection, ocrelizumab, 1 mg | 24 | 15 | $455K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,438 | 1,189 | $350K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 9,171 | 8,796 | $343K |
| 93975 | 2,615 | 2,195 | $339K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,758 | 2,959 | $273K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2,829 | 1,539 | $265K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,132 | 958 | $256K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2,582 | 2,273 | $235K |
| 70498 | 910 | 733 | $222K | |
| 87631 | 2,307 | 2,184 | $216K | |
| 96415 | 710 | 459 | $209K | |
| 90839 | 1,488 | 1,171 | $188K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,773 | 4,229 | $177K |
| 70491 | 534 | 449 | $160K | |
| 76770 | 1,035 | 891 | $158K | |
| 81513 | 1,195 | 946 | $153K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 625 | 537 | $150K |
| 93458 | 139 | 113 | $145K | |
| 58661 | 88 | 53 | $143K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 375 | 296 | $132K |
| 96127 | 1,442 | 1,213 | $130K | |
| 93799 | 21,399 | 8,035 | $114K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,257 | 2,038 | $109K |
| 76642 | 893 | 808 | $105K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 303 | 221 | $105K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 43,614 | 34,502 | $103K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 79 | 67 | $102K |
| 96367 | 1,980 | 1,304 | $101K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 706 | 580 | $101K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 743 | 683 | $99K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 227 | 150 | $94K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 61 | 50 | $93K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 185 | 169 | $91K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 85,628 | 69,885 | $85K |
| 58558 | 67 | 49 | $85K | |
| 86850 | 4,616 | 3,696 | $85K | |
| 84484 | 25,848 | 15,536 | $81K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,848 | 4,590 | $80K |
| 0002A | 2,109 | 2,095 | $79K | |
| 0001A | 2,122 | 2,078 | $77K | |
| 93970 | 662 | 540 | $76K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 13,146 | 8,495 | $74K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 677 | 582 | $74K |
| 97161 | 2,303 | 1,874 | $72K | |
| 96161 | 463 | 416 | $71K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,575 | 1,413 | $70K |
| 97535 | Self-care/home management training, each 15 minutes | 2,863 | 1,768 | $69K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 4,990 | 3,749 | $69K |
| 71250 | 844 | 772 | $68K | |
| 93798 | 1,450 | 235 | $68K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 560 | 460 | $67K |
| 12001 | 429 | 372 | $65K | |
| 93971 | 1,139 | 979 | $63K | |
| 36415 | Collection of venous blood by venipuncture | 86,693 | 54,406 | $62K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 430 | 400 | $62K |
| 71046 | Radiologic examination, chest; 2 views | 9,351 | 8,261 | $61K |
| 99222 | Initial hospital care, per day, moderate complexity | 1,540 | 1,483 | $60K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 668 | 549 | $59K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 10,399 | 9,035 | $58K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,856 | 809 | $53K |
| 74183 | 277 | 235 | $53K | |
| 12011 | 334 | 300 | $52K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 183 | 131 | $52K |
| 44970 | 24 | 14 | $50K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 2,650 | 1,543 | $48K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,570 | 1,440 | $48K |
| 76536 | 477 | 437 | $44K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,357 | 557 | $43K |
| 86900 | 4,668 | 3,723 | $43K | |
| 85027 | 17,873 | 11,647 | $43K | |
| 96160 | 215 | 174 | $39K | |
| 92551 | 769 | 672 | $39K | |
| 88307 | 410 | 317 | $39K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 331 | 283 | $38K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 130 | 117 | $37K |
| 54150 | 835 | 806 | $36K | |
| 90651 | 729 | 597 | $36K | |
| 84443 | Thyroid stimulating hormone (TSH) | 4,765 | 3,882 | $35K |
| 19083 | 51 | 38 | $35K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 29,056 | 24,658 | $34K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 717 | 315 | $34K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 683 | 641 | $33K |
| 71045 | Radiologic examination, chest; single view | 15,304 | 12,996 | $32K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8,925 | 5,343 | $32K |
| 82962 | 22,650 | 7,292 | $32K | |
| 97165 | 936 | 758 | $30K | |
| 82805 | 1,127 | 849 | $30K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 28 | 24 | $28K |
| 76830 | Ultrasound, transvaginal | 1,259 | 1,056 | $27K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3,802 | 3,109 | $27K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,191 | 678 | $27K |
| 97802 | 607 | 478 | $26K | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 291 | 217 | $26K |
| 90670 | 3,741 | 3,303 | $26K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 147 | 106 | $26K |
| 83735 | 26,938 | 18,989 | $25K | |
| 99152 | 1,752 | 1,360 | $25K | |
| 36561 | 28 | 26 | $25K | |
| 90686 | 3,632 | 3,017 | $24K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3,807 | 3,110 | $24K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,623 | 1,390 | $24K |
| 80061 | Lipid panel | 2,474 | 2,091 | $23K |
| 99219 | 667 | 647 | $23K | |
| 74018 | 1,423 | 1,213 | $23K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 8,941 | 7,544 | $22K |
| 93017 | 344 | 268 | $22K | |
| 10060 | 140 | 125 | $21K | |
| 77336 | 260 | 125 | $21K | |
| 84702 | 5,055 | 4,062 | $21K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,578 | 2,134 | $21K |
| 97116 | 1,053 | 649 | $21K | |
| 70486 | 838 | 709 | $21K | |
| 82728 | 1,774 | 1,486 | $20K | |
| 76882 | 209 | 182 | $20K | |
| 77062 | 509 | 468 | $20K | |
| 73610 | 1,708 | 1,450 | $20K | |
| 81001 | 40,096 | 35,208 | $19K | |
| Q3014 | Telehealth originating site facility fee | 729 | 700 | $19K |
| 84439 | 1,702 | 1,379 | $19K | |
| 99233 | Prolong inpt eval add15 m | 851 | 555 | $18K |
| 72131 | 355 | 297 | $18K | |
| 86140 | 3,953 | 3,252 | $18K | |
| 86780 | 1,727 | 1,502 | $18K | |
| 77061 | 464 | 421 | $18K | |
| 87505 | 151 | 115 | $17K | |
| 90715 | 1,690 | 1,276 | $17K | |
| 64615 | 89 | 76 | $16K | |
| 36430 | 71 | 60 | $16K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4,477 | 3,431 | $16K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 123 | 112 | $16K |
| 90648 | 2,064 | 1,774 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,938 | 1,552 | $15K |
| 97162 | 531 | 460 | $15K | |
| 72100 | 962 | 852 | $14K | |
| 94060 | 240 | 220 | $14K | |
| 87340 | 1,118 | 924 | $14K | |
| 73630 | 1,583 | 1,380 | $13K | |
| 73130 | 1,307 | 1,106 | $13K | |
| 83540 | 1,871 | 1,587 | $13K | |
| 73564 | 872 | 778 | $13K | |
| 70496 | 951 | 767 | $13K | |
| 90633 | 1,626 | 1,364 | $12K | |
| 36591 | 426 | 313 | $12K | |
| 86803 | 791 | 694 | $12K | |
| 77065 | Tomosynthesis, mammo | 686 | 590 | $12K |
| 73110 | 1,084 | 920 | $12K | |
| 86762 | 430 | 378 | $12K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 65 | 51 | $11K |
| 96416 | 105 | 51 | $11K | |
| 72197 | 58 | 49 | $11K | |
| 73030 | 1,477 | 1,188 | $11K | |
| 90698 | 1,765 | 1,563 | $11K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 670 | 571 | $11K |
| 96376 | 7,503 | 3,660 | $11K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 514 | 483 | $11K |
| 76857 | 716 | 612 | $10K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 74 | 38 | $10K |
| 49083 | 24 | 13 | $10K | |
| 83550 | 1,852 | 1,573 | $10K | |
| 82607 | 1,125 | 894 | $10K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,098 | 877 | $10K |
| 86901 | 4,668 | 3,723 | $10K | |
| 74019 | 1,026 | 887 | $10K | |
| 72141 | 74 | 65 | $10K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 819 | 707 | $10K |
| 85610 | 12,135 | 7,475 | $10K | |
| 87481 | 1,082 | 853 | $10K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 5,086 | 4,634 | $10K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,200 | 1,010 | $9K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 67 | 58 | $9K |
| 71271 | 81 | 71 | $9K | |
| 77300 | 14 | 14 | $9K | |
| 96368 | 652 | 412 | $9K | |
| 90680 | 2,261 | 1,974 | $9K | |
| 96112 | 30 | 30 | $9K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 623 | 557 | $8K |
| 99153 | Mod sedat endo service >5yrs | 1,147 | 875 | $8K |
| 94660 | 141 | 58 | $8K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 13,089 | 8,767 | $8K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2,702 | 2,208 | $8K |
| 99221 | 292 | 283 | $8K | |
| 73502 | 970 | 805 | $8K | |
| 52000 | 12 | 12 | $8K | |
| 82533 | 737 | 496 | $8K | |
| 90677 | 363 | 338 | $8K | |
| 43235 | 12 | 12 | $8K | |
| 83880 | 3,734 | 2,928 | $7K | |
| 73560 | 1,188 | 963 | $7K | |
| 92552 | 100 | 74 | $7K | |
| 82024 | 548 | 379 | $7K | |
| 80069 | 709 | 468 | $7K | |
| 77066 | Tomosynthesis, mammo | 574 | 525 | $7K |
| 73590 | 956 | 797 | $7K | |
| 82784 | 766 | 642 | $7K | |
| 82570 | 1,210 | 971 | $6K | |
| 90688 | 530 | 403 | $6K | |
| 76801 | 391 | 326 | $6K | |
| 0004A | 181 | 174 | $6K | |
| 90723 | 1,561 | 1,333 | $6K | |
| 80076 | 745 | 576 | $6K | |
| 51798 | 862 | 690 | $6K | |
| A9270 | Non-covered item or service | 4,359 | 1,722 | $6K |
| 99223 | Prolong inpt eval add15 m | 124 | 119 | $5K |
| 99217 | 213 | 213 | $5K | |
| 12002 | 35 | 29 | $5K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,480 | 600 | $5K |
| 88341 | 119 | 85 | $5K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 245 | 191 | $5K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 96 | 81 | $5K |
| 87510 | 280 | 224 | $5K | |
| 84100 | 2,316 | 1,392 | $5K | |
| 87077 | 2,351 | 1,910 | $5K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5,091 | 4,224 | $5K |
| S9443 | Lactation classes, non-physician provider, per session | 101 | 83 | $4K |
| 82077 | 4,250 | 3,155 | $4K | |
| 0054A | 283 | 280 | $4K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 913 | 463 | $4K |
| 0124A | 140 | 132 | $4K | |
| 97166 | 192 | 157 | $4K | |
| 83690 | 11,197 | 9,273 | $4K | |
| 00840 | 891 | 595 | $4K | |
| 58300 | 31 | 25 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,132 | 1,664 | $4K |
| 86923 | 121 | 93 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,168 | 932 | $4K |
| 86706 | 521 | 412 | $4K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 37 | 25 | $4K |
| 0071A | 115 | 114 | $4K | |
| 74174 | 65 | 52 | $4K | |
| 25600 | 13 | 12 | $4K | |
| 83970 | 185 | 138 | $4K | |
| 77080 | 67 | 60 | $3K | |
| J1815 | Injection, insulin, per 5 units | 342 | 231 | $3K |
| 83655 | 179 | 154 | $3K | |
| 94729 | 155 | 145 | $3K | |
| 76870 | 343 | 280 | $3K | |
| J3490 | Unclassified drugs | 222 | 156 | $3K |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 35 | 25 | $3K |
| 73080 | 472 | 402 | $3K | |
| 0072A | 92 | 90 | $3K | |
| 99253 | 74 | 73 | $3K | |
| 73090 | 668 | 557 | $3K | |
| 99239 | Hospital discharge day management, more than 30 minutes | 82 | 81 | $3K |
| 73140 | 423 | 360 | $3K | |
| 85652 | 1,123 | 958 | $3K | |
| 73552 | 529 | 427 | $3K | |
| 90480 | 153 | 125 | $3K | |
| 81025 | 10,314 | 8,712 | $3K | |
| 87660 | 283 | 225 | $3K | |
| 93880 | 29 | 29 | $3K | |
| 87070 | 1,991 | 1,743 | $3K | |
| 90685 | 407 | 326 | $3K | |
| 82950 | 190 | 175 | $2K | |
| 90744 | 505 | 421 | $2K | |
| 64450 | 19 | 12 | $2K | |
| 73700 | 25 | 25 | $2K | |
| 82550 | 2,151 | 1,462 | $2K | |
| 84156 | 953 | 730 | $2K | |
| 87653 | 163 | 134 | $2K | |
| 72170 | 1,086 | 893 | $2K | |
| 81003 | 3,369 | 2,779 | $2K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 57 | 57 | $2K |
| 90697 | 255 | 237 | $2K | |
| 90619 | 195 | 166 | $2K | |
| 73060 | 491 | 383 | $2K | |
| 0003A | 57 | 57 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 13 | 13 | $2K |
| 86038 | 128 | 99 | $2K | |
| 80320 | 389 | 352 | $2K | |
| 82746 | 618 | 491 | $2K | |
| 85730 | 3,263 | 2,279 | $2K | |
| 85018 | 1,387 | 1,061 | $2K | |
| 86364 | 136 | 118 | $2K | |
| 83605 | 3,620 | 2,341 | $2K | |
| 96523 | 44 | 28 | $2K | |
| 90696 | 248 | 209 | $2K | |
| 90474 | 1,278 | 1,178 | $2K | |
| 87186 | 1,640 | 1,333 | $2K | |
| 99220 | 28 | 26 | $2K | |
| 74220 | 31 | 31 | $2K | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 42 | 38 | $2K |
| 90461 | 1,817 | 1,548 | $2K | |
| 90710 | 379 | 311 | $2K | |
| 72050 | 49 | 43 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 2,867 | 1,862 | $2K |
| 87493 | 123 | 90 | $2K | |
| 82947 | 1,220 | 936 | $2K | |
| 86258 | 97 | 81 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,446 | 2,873 | $1K |
| J1453 | Injection, fosaprepitant, 1 mg | 115 | 64 | $1K |
| 84145 | 845 | 692 | $1K | |
| 87040 | 1,921 | 1,527 | $1K | |
| 90656 | 190 | 188 | $1K | |
| 99254 | 27 | 27 | $1K | |
| 72040 | 89 | 80 | $1K | |
| 85379 | 2,931 | 2,419 | $1K | |
| 72128 | 42 | 36 | $1K | |
| 90716 | 232 | 175 | $1K | |
| 00731 | 598 | 451 | $1K | |
| 82330 | 1,347 | 951 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,213 | 496 | $1K |
| 83615 | 371 | 303 | $1K | |
| 71101 | 186 | 140 | $1K | |
| 84703 | 2,587 | 2,113 | $1K | |
| 99215 | Prolong outpt/office vis | 30 | 29 | $1K |
| 86003 | 28 | 27 | $1K | |
| 82565 | 178 | 135 | $1K | |
| 87205 | 1,094 | 864 | $1K | |
| 99252 | 41 | 38 | $1K | |
| 86703 | 755 | 639 | $1K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 52 | 51 | $1K |
| 84132 | 1,899 | 1,472 | $1K | |
| 82105 | 84 | 73 | $1K | |
| 99381 | 92 | 50 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,722 | 911 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 17,555 | 13,232 | $1K |
| 96402 | 114 | 77 | $925.74 | |
| 82043 | 179 | 156 | $925.53 | |
| 87480 | 280 | 224 | $902.57 | |
| J1644 | Injection, heparin sodium, per 1000 units | 6,146 | 2,507 | $882.17 |
| 86308 | 424 | 365 | $865.59 | |
| 82375 | 1,517 | 1,173 | $833.99 | |
| 84153 | 102 | 90 | $830.91 | |
| 82150 | 1,033 | 855 | $821.94 | |
| 80143 | 476 | 382 | $814.94 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 9,240 | 6,646 | $797.81 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 75 | 53 | $790.89 |
| 82553 | 275 | 168 | $786.59 | |
| 01844 | 19 | 12 | $774.66 | |
| 74230 | 13 | 12 | $773.97 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 105 | 96 | $720.74 |
| C9113 | Injection, pantoprazole sodium, per vial | 716 | 315 | $717.56 |
| 86704 | 79 | 64 | $716.39 | |
| 87522 | Neg quan hep c or qual rna | 31 | 26 | $709.18 |
| 84146 | 77 | 65 | $645.85 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 391 | 326 | $644.13 |
| 84550 | 219 | 181 | $608.92 | |
| 73070 | 58 | 51 | $607.91 | |
| 94726 | 13 | 12 | $580.15 | |
| 87486 | 96 | 81 | $575.92 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 10,352 | 8,388 | $575.07 |
| 93321 | 17 | 13 | $540.02 | |
| J2704 | Injection, propofol, 10 mg | 7,779 | 4,783 | $536.16 |
| 0064A | 22 | 21 | $533.28 | |
| 90707 | 165 | 143 | $528.31 | |
| 82435 | 1,051 | 798 | $524.00 | |
| 86870 | 14 | 13 | $500.43 | |
| 36416 | 2,672 | 2,071 | $497.24 | |
| 82378 | 88 | 77 | $496.06 | |
| 85045 | 211 | 164 | $484.56 | |
| 84165 | 134 | 109 | $480.09 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 9,008 | 5,851 | $458.95 |
| 83521 | 69 | 56 | $456.67 | |
| 72072 | 101 | 87 | $452.62 | |
| 92526 | 17 | 12 | $450.01 | |
| 90658 | 46 | 46 | $432.12 | |
| 84403 | 30 | 25 | $429.48 | |
| 84155 | 159 | 141 | $409.88 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 424 | 208 | $398.06 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 413 | 283 | $393.85 |
| 99218 | 12 | 12 | $387.06 | |
| 92611 | 13 | 12 | $385.01 | |
| J9045 | Injection, carboplatin, 50 mg | 45 | 26 | $384.63 |
| 86334 | 31 | 24 | $355.01 | |
| 87420 | 17 | 12 | $351.79 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,428 | 1,910 | $349.25 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 15,945 | 11,115 | $343.51 |
| 84450 | 104 | 89 | $342.27 | |
| 84460 | 109 | 93 | $333.34 | |
| 90700 | 73 | 55 | $332.75 | |
| 80179 | 454 | 356 | $327.59 | |
| 87581 | 100 | 82 | $320.07 | |
| 00811 | 76 | 65 | $317.22 | |
| 84295 | 1,117 | 843 | $285.37 | |
| 82977 | 23 | 12 | $284.86 | |
| 99442 | 14 | 13 | $283.53 | |
| 83050 | 1,140 | 852 | $278.52 | |
| J1940 | Injection, furosemide, up to 20 mg | 585 | 262 | $274.45 |
| 99441 | 27 | 26 | $272.21 | |
| 0052A | 30 | 30 | $269.26 | |
| J2785 | Injection, regadenoson, 0.1 mg | 294 | 220 | $261.72 |
| 88304 | 581 | 458 | $258.34 | |
| 00400 | 127 | 86 | $250.10 | |
| 86355 | 42 | 27 | $244.10 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,155 | 1,981 | $239.25 |
| 88342 | 385 | 295 | $236.80 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 811 | 356 | $225.98 |
| 77001 | 137 | 107 | $217.28 | |
| 82010 | 631 | 497 | $215.23 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 438 | 295 | $208.07 |
| 73000 | 16 | 12 | $205.98 | |
| 87808 | 90 | 73 | $203.27 | |
| 0051A | 23 | 23 | $190.18 | |
| 82140 | 105 | 78 | $186.73 | |
| 82525 | 48 | 39 | $180.74 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 795 | 553 | $172.85 |
| 80177 | 109 | 92 | $168.40 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,278 | 1,452 | $165.80 |
| J3370 | Injection, vancomycin hcl, 500 mg | 702 | 410 | $159.94 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 875 | 619 | $142.19 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 3,516 | 2,609 | $137.68 |
| 85014 | 16 | 13 | $133.96 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 412 | 314 | $126.86 |
| J2060 | Injection, lorazepam, 2 mg | 1,131 | 769 | $122.56 |
| 84630 | 22 | 16 | $120.58 | |
| 80164 | 50 | 39 | $119.80 | |
| 84481 | 32 | 27 | $117.82 | |
| 82270 | 222 | 183 | $111.22 | |
| 87641 | 87 | 64 | $109.73 | |
| 94760 | 7,079 | 3,925 | $107.28 | |
| 90734 | 29 | 26 | $105.60 | |
| J1790 | Injection, droperidol, up to 5 mg | 1,073 | 826 | $103.59 |
| 74022 | 13 | 12 | $102.02 | |
| 96417 | 802 | 422 | $94.57 | |
| 87430 | 24 | 22 | $92.04 | |
| 84425 | 16 | 13 | $87.66 | |
| 91300 | 4,537 | 4,145 | $85.25 | |
| 87640 | 87 | 64 | $84.60 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,405 | 1,068 | $83.88 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,752 | 894 | $82.18 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 667 | 483 | $74.57 |
| 86665 | 15 | 12 | $69.03 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 77 | 65 | $68.79 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,851 | 5,068 | $67.86 |
| J3480 | Injection, potassium chloride, per 2 meq | 1,397 | 901 | $66.92 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,431 | 1,006 | $64.78 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 990 | 751 | $56.53 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 36 | 36 | $55.59 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 1,435 | 1,242 | $55.37 |
| 82040 | 12 | 12 | $50.66 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 149 | 79 | $46.06 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 119 | 108 | $41.80 |
| 81002 | 558 | 353 | $39.31 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 628 | 549 | $38.74 |
| J7030 | Infusion, normal saline solution , 1000 cc | 705 | 371 | $38.29 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 647 | 478 | $36.70 |
| C1769 | Guide wire | 1,225 | 941 | $33.65 |
| J7999 | Compounded drug, not otherwise classified | 15 | 12 | $33.59 |
| 80175 | 13 | 12 | $30.78 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 297 | 204 | $29.75 |
| C1729 | Catheter, drainage | 236 | 153 | $26.82 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 785 | 491 | $26.25 |
| 94761 | 64 | 50 | $22.94 | |
| 87529 | 12 | 12 | $19.59 | |
| 87088 | 45 | 44 | $17.82 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 424 | 304 | $17.06 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 117 | 107 | $15.87 |
| J7050 | Infusion, normal saline solution, 250 cc | 2,344 | 1,004 | $14.70 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,828 | 2,661 | $14.20 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 788 | 676 | $12.29 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 15 | 14 | $9.01 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 87 | 40 | $6.54 |
| J0456 | Injection, azithromycin, 500 mg | 282 | 135 | $5.98 |
| J1630 | Injection, haloperidol, up to 5 mg | 40 | 26 | $5.66 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 40 | 39 | $5.35 |
| J1171 | Injection, hydromorphone, 0.1 mg | 103 | 76 | $5.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 1,138 | 935 | $4.12 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 254 | 152 | $3.51 |
| 91307 | 319 | 299 | $2.54 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 96 | 38 | $2.52 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 119 | 114 | $1.81 |
| 91305 | 359 | 353 | $1.39 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 57 | 56 | $1.03 |
| 91312 | 100 | 100 | $0.55 | |
| 91306 | 20 | 20 | $0.14 | |
| 3079F | 199 | 177 | $0.00 | |
| A4648 | Tissue marker, implantable, any type, each | 204 | 163 | $0.00 |
| 3074F | 2,459 | 2,284 | $0.00 | |
| 00790 | 229 | 174 | $0.00 | |
| C1781 | Mesh (implantable) | 21 | 13 | $0.00 |
| 00126 | 18 | 14 | $0.00 | |
| 3075F | 206 | 191 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 99 | 57 | $0.00 |
| 76377 | 52 | 50 | $0.00 | |
| C1726 | Catheter, balloon dilatation, non-vascular | 64 | 56 | $0.00 |
| J2305 | Injection, nitroglycerin, 5 mg | 34 | 33 | $0.00 |
| 00142 | 13 | 12 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 43 | 34 | $0.00 |
| 00952 | 94 | 65 | $0.00 | |
| 3044F | 29 | 26 | $0.00 | |
| 3077F | 304 | 267 | $0.00 | |
| 3078F | 2,902 | 2,687 | $0.00 | |
| 87220 | 47 | 42 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 242 | 219 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 391 | 309 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 14 | 12 | $0.00 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 12 | 12 | $0.00 |
| C2625 | Stent, non-coronary, temporary, with delivery system | 117 | 87 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 234 | 168 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 282 | 247 | $0.00 |
| 88112 | 54 | 48 | $0.00 | |
| J9190 | Injection, fluorouracil, 500 mg | 107 | 51 | $0.00 |
| 88302 | 20 | 12 | $0.00 | |
| 87210 | 49 | 43 | $0.00 | |
| C1788 | Port, indwelling (implantable) | 45 | 39 | $0.00 |
| 29125 | 17 | 12 | $0.00 | |
| 00910 | 17 | 12 | $0.00 |